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Abstract
Background: Bloodstream infection (BSI) is a major public health concern due to its severity-related consequences. These infections pose a human health 
risk, as they can result in human morbidity and mortality over a short period of time. Blood culture remains the gold standard and major tool for the 
diagnosis of BSI. Blood culture sampling is commonly indicated before administering antimicrobial therapy, whereas the daily therapeutic adjustment to the 
antibiogram is an effective intervention in management of BSIs. Compliance with the microbiological criteria-based protocols for pathogen identification 
and antimicrobial susceptibility testing allow treatment correction within 48-72 hours. Interpretation of positive blood cultures may sometimes present 
a dilemma for clinicians and microbiologists and, therefore, the test findings should be evaluated in the context of the clinical picture.
Conclusions: Over the last decades, we have witnessed an outbreak in the number of BSI studies. The implementation of a standardized algorithm on 
criteria of a complete blood count sampling, processing and interpretation of the results will help increase the yield rate of BSI pathogens and ultimately 
improve care management of the patients with BSI. The education and training of medical staff, engaged in BSI patient care is vital in developing good 
practice, preventing blood culture contamination and obtaining fast and accurate outcomes.
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Introduction
Bloodstream infection (BSI) has become a subject of 
medical concern worldwide due to its severity-related con-
sequences. BSI represents a growing public health concern, 
with an estimated burden of 1.200.000 episodes across 
Europe and 157.000 deaths annually [1]. 
The reviewed studies highlight the most common mi-
crobial agents involved in the aetiology of BSI, namely: 
Escherichia coli, Staphylococcus aureus and Streptococcus 
pneumoniae, with approximately 35%, 25% and 10% per 
100.000 population, respectively. These studies revealed that 
BSI incidence varies significantly across different geograph-
ic regions, and this is largely due to timing of BC specimen 
collection, demographic population differences and distri-
bution of risk factors within these regions [2].
These infections show high morbidity and mortality 
rates across the globe and are among the top seven causes of 
death in North America and Europe [3].
However, accurate data on the incidence of BSI-associ-
ated morbidity and mortality in some countries are limited, 
due to misdiagnosis and insufficient patient follow-up [4-8].
The risk of BSI is due to the immunocompromised hu-
man organism that might favor the invasion of various 
pathogens, which commonly show resistance to a number 
of antimicrobial groups [9, 10].
BSI diagnosis is based on the detection of bacterial and 
fungal pathogen isolates from the blood cultures. Over the 
recent decades, great progress has been made in the de-
velopment of rapid diagnostic tests based on innovative 
technologies; BC sampling remains the gold standard for 
diagnosis of BSIs. This method is one of the most impor-
tant techniques if any BSI-related suspicions arise. Blood, 
being normally sterile, has a considerable diagnostic signifi-
cance in isolating and identifying bacteria or fungi from the 
blood cultures. It allows establishing the diagnosis for BSI 
by isolating and rapidly identifying the pathogen (within 
2-7 days). Moreover, it guides the physician in choosing 
the antimicrobial therapy based on the results of Antimi-
crobial Susceptibility Testing (AST) of pathogen isolates to 
antimicrobial drugs, thereby contributing to reducing the 
phenomenon of antibiotic resistance [11]. 
 Most studies have reported variations, from country to 
country, on recommendations for good blood culture sam-
pling practices [12-14].
At present, there are international guidelines on the col-
lection, processing, interpretation of blood cultures, where-
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as this paper will present the rigors stipulated therein [15-
18].
Despite the fact that, there are guidelines, method-
ologies, instructions on BC sampling, however inadequate 
practices continue to be registered, which exhibit an ap-
proximately 3% rate of blood culture contamination  [19].
Blood culture contamination produces false-positive 
results, leading to irrational use of antimicrobial drugs, in-
creased length of hospitalization and higher costs [20].
Furthermore, the authors of the studies highlight the im-
portance of accurate diagnosis for BSI, which requires both 
laboratory findings on isolation of the microbial agent from 
blood cultures and presence of compatible clinical signs of 
the patient. The same studies show that the pathogen, de-
tected as an etiological agent for BSI, should be, preferably, 
isolated from several blood samples. Moreover, studies rec-
ommend identifying the site of primary infection and iso-
lating the same microbial agent from this outbreak [21].
According to some studies, in most cases, only 5 to 13% 
of blood cultures turn out to be positive with isolation of the 
microbial agents, and of those, 20–56% represent the con-
taminating microbial flora, despite the scientific advance in 
the use of skin antiseptics, which have been successful since 
25 years ago, and thus, reducing the risk of contamination 
by 2.1-6% [22, 23].
Effective management in reducing the overall incidence 
of BSI is a major reason for indicating BC sampling prior to 
the administration of antimicrobial therapy, as well as for 
daily reassessment and appropriate adjustment of this ther-
apy based on definitive pathogen identification and antimi-
crobial susceptibility testing to antimicrobial preparations. 
Since BSI patient survival is inversely proportional to time 
of initiation of appropriate antimicrobial therapy, it is vital 
to obtain the BC results as soon as possible. Therefore, early 
diagnosis and appropriate treatment are crucial in the effi-
cient management of BSI. Delays in the initiation of antimi-
crobial treatment may lower dramatically the survival rate 
among BSI patients. Patients treated within the first hour 
of diagnosis may have a survival rate of almost 80%, subse-
quently, the chances of survival decrease by 7.6% for every 
hour after. Inappropriate initial antimicrobial treatment is 
likely to be fatal in these patients [5].
Key terms and definitions
Antiseptic. A substance that inhibits the growth and de-
velopment of microorganisms [24].
Bloodstream infection. A bacteria or fungi-associated 
infection [24].
Bacteremia. The presence of bacteria in the blood. It 
may be transient, intermittent or continuous [24]. 
Transient bacteremia / fungemia. Transient presence 
of bacteria or fungi in the blood for a period of several min-
utes [24].
Intermittent bacteremia. Intermittent BSI is a “recur-
rent transient infection” that is associated with undrained 
and intra-abdominal abscesses [24].
Continuous bacteremia. Continuous bacteremia sug-
gests a severe infection that inhibited the host’s defense 
mechanisms. It is a characteristic of BSI, such as infective 
endocarditis or suppurative thrombophlebitis [24].
Pseudobacteriemia. Pseudobacteremia occurs when 
blood culture isolates come from outside the patient’s 
bloodstream [24].
SIRS (Systemic Inflammatory Response Syndrome). 
Systemic inflammatory response syndrome features the ear-
ly body response to damages of infectious or non-infectious 
origin [25-27].
Sepsis. Life-threatening organic dysfunction caused by 
impaired host response to infection [28, 29].
Septic shock. It is defined as a subgroup of sepsis, as-
sociated in particular with profound circulatory, cellular 
metabolism abnormalities, with a higher risk of death than 
sepsis [30]. 
Neonatal sepsis. Neonatal sepsis is defined as clinically 
diagnosed SIRS, caused by infection occurring within the 
first four weeks after birth. The incidence of neonatal sepsis 
increases with early-onset birth weight decrease and can be 
divided into two types: early-onset neonatal sepsis (occurs 
in the first 72 hours of life); late-onset neonatal sepsis (oc-
curs after the first 72 hours of life) [31].
Bloodstream infections in immunocompetent pa-
tients include:
Community-acquired infection. Bacteremia and fun-
gemia may often occur in previously healthy individuals, 
commonly associated with focal infections such as pneumo-
coccal pneumonia. Moreover, bacteria can penetrate into 
the bloodstream from the patient’s own commensal flora 
or from an undetectable infected site, leading to metastatic 
infections [31].
Hospital-acquired infection.  The increased number of 
invasive procedures, such as catheterization, immunosup-
pressive therapy, antibiotic therapy and life support mea-
sures, has resulted in higher overall incidence of hospital-ac-
quired bacteremia, candidemia and other fungal infections. 
These procedures may allow microorganisms to invade into 
the blood or weaken the host defense system [31].
Health care-associated infections (HCAIs).  HCAIs are 
infections that occur as a result of medical assistance and 
treatment procedures within outpatient care units, medical 
offices, healthcare clinics or hospitals [31].
Anaerobic bacteremia.  Studies have shown that an-
aerobic microorganisms make up 1-17% of positive blood 
cultures. Anaerobic microorganisms are a common cause of 
bacteremia and, therefore, routine testing should be carried 
out [31].
Pediatric BSI.  The etiology of pediatric bacteremia 
has changed over the last few years. Haemophilus influen-
zae type b (Hib) infections decreased dramatically after the 
introduction of national immunization programs, whereas 
the systemic HCAIs have increased [31].
Catheter-related bloodstream infections.  Intravenous 
catheter (IVC)-related bacteremia or fungemia are difficult 
to confirm. There is often no evidence of infection at the 
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catheter insertion site, whereas the involved microorgan-
isms are part of the normal skin flora and common con-
taminants of BCs [31].
Infective endocarditis (IE).  IE is defined as an infec-
tion of the endocardium, particularly involving the heart 
valves, characterized by functional impairment, and termed 
as an infection of the heart valves and / or other endocar-
dium areas [31].
BSI in immunocompromised patients.  Immunocom-
promised patients are individuals with acquired or drug-in-
duced autoimmune disorders. Defects in phagocytes, com-
plement, antibody response and cell-mediated immunity are 
often associated with specific disorders or conditions, such 
as malignancy, HIV infection, organ transplantation, immu-
nosuppressive therapies, and steroid administration. Patients 
with neutropenia are at highest risk of infection [31].
Recommendations for blood culture sampling
Most of the reviewed studies highlight the importance of 
doctor’s indication for BC sampling in patients exhibiting 
the following signs: septicemia, septic shock; severe local-
ized infections (meningitis, pneumonia, intra-abdominal 
abscess); fever or fever history and suspected or detected 
neutropenia; fever and immunocompromised status; indi-
viduals undergoing invasive procedures (catheter, dialysis 
or surgery); fever and recent trips abroad; suspected bacte-
rial endocarditis; syndromes, suggestive of BSIs with spe-
cific germs (enteric fever, brucellosis, leptospirosis), under 
certain conditions (like pregnancy, cardiac diseases, diabe-
tes, renal failure, hepatic failure, leukocytosis, granulocyto-
penia) [32, 33].
However, the academic society has not come to a com-
mon denominator on the best clinical predictors for BSIs 
[34, 35].
Key elements and general principles for  
blood culture sampling
The research underlines the importance of standardiza-
tion of the blood sampling procedure for microbiological 
investigations. Therefore, the study outcomes on the imple-
mentation of a standardized procedure of BC sampling per-
formed under aseptic conditions , showed a reduction in the 
contamination rate up to 1.6% (p <0.001), with a previously 
recorded rate of 3.9% [36]. According to another study by 
Self et al. (2013) on the development and implementation 
of a standardized set of sterile tools required for blood sam-
pling , as well as the user’s checklist, the contamination rate 
decreased from 4.3% to 1.7% (p <0.001) [9, 37].
The studies emphasize the importance of timing blood 
sampling and recommend to be collected soon after the 
clinical signs appear and before the initiation of antimicro-
bial therapy. In case if, due to certain circumstances, the 
patient is already undergoing antimicrobial therapy, blood 
sampling should be carried out immediately prior to ad-
ministering the next dose and by inoculating the blood into 
bottles containing specialized antimicrobial neutralization 
media. It is not recommended to collect blood through the 
same needle / lumen through which an antimicrobial drug 
has been given within the last hour. Information on previ-
ously administered antimicrobial preparations should be 
indicated on the laboratory application form [32, 10].
First, blood samples must be collected from the periph-
eral vein. Sets withdrawn from either the central or the pe-
ripheral vessels must be taken successively or at intervals of 
12 hours apart. To obtain reliable BC data, the peripheral 
blood samples are taken first before other types of investiga-
tions [38, 17].
Some authors of the recent studies do not recommend 
blood sampling through the peripheral intravenous cannu-
la. Moreover, there is also an obvious risk of contamination 
due to the difficulty of skin disinfection when taking blood 
from a femoral vein. Therefore, the authors suggest avoid-
ing these sites and, and if no other options for sampling are 
available, this procedure will be carried out by document-
ing into the patient’s sample accompanying form or clinical 
record [39, 40].
The study analysis reveals the number and amount of 
sampling, required to obtain reliable and accurate results. 
To optimize the yield of bacteria and fungi in the blood, 
an adequate amount of blood is required. A sufficient vol-
ume of blood sampling allows a better detection of small 
amounts of bacterial or fungal pathogens. It is essential in 
case if an endovascular infection (such as endocarditis) is 
suspected. The blood volume obtained for each BC set is 
the most important variable when isolating microorganisms 
from patients with BSIs [38].
The blood amount collected from both sampling sites 
must be sufficient to ensure BC accuracy, e.g. if only 10 ml of 
blood is obtained from the peripheral vein, additional 10 ml 
is taken from the central vein. When collecting blood from 
both central and peripheral veins, the sampling site is clearly 
indicated on the culture bottle and reference sheet [41].
Researchers demonstrated that blood culture bottles are 
designed to accommodate the optimal blood- to-broth ratio 
(1:5 to 1:10) and to allow maximum bacterial and fungal 
isolation. Commercial continuous monitoring blood cul-
ture systems may use a lower blood / broth ratio (<1:5) due 
to added sodium polyanethol sulfonate or sodium citrate , 
non-toxic anticoagulants that promote bacterial prolifera-
tion by neutralizing the bactericidal activity of human se-
rum and inhibiting the action of some antibiotics [42].
Most studies have reported that adult bacteremia and 
fungemia in adults commonly develop with a reduced 
amount of circulating microorganisms, ranging from 1-30 
colony-forming units per mL (CFU / mL) of blood. The 
concentration is over 100 CFU / mL in newborns, babies 
and older children, therefore the volume of blood sampling 
differs in both adults and children. For an adult, the recom-
mended blood volume to be obtained per culture is 20 to 30 
ml [32, 42, 43].
The standard indicates that BC set should include two 
bottles (for aerobic and anaerobic microorganisms), and 
about 10 ml of blood should be collected per each in adults. 
This volume is required to optimize pathogen isolation 
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when the amount of bacteria or fungi is less than 1 UFC / 
mL of blood. Two or three bottle sets (two bottles per set) 
are recommended to be used for each septic episode, viz.  in 
adults, 40-60 mL of blood is collected for 4-6 bottles, 10 mL 
per each bottle [44].
Few studies have been carried out on the optimum 
blood volume taken from infants and children, however, the 
available data indicate that the yield of pathogens also in-
creases in direct proportion to the volume of blood cultured 
and inoculated. Also, the recommended blood volume to be 
collected should depend on the patient’s body weight, and 
only one aerobic bottle is used, if no anaerobic infection is 
suspected. In this context, in children under 2 years, specifi-
cally designed bottles to maintain the blood-to-broth ratio 
(1:5 to 1:10) are used, with smaller blood volumes [32, 45].
The researchers have shown that, as bacteria and fungi 
are not always present in the bloodstream; the sensitivity of 
a single BC set might be compromised.
The study results on the cumulative sensitivity of blood 
cultures, using continuous-monitoring blood culture sys-
tems for 24 hours demonstrated that four blood cultures 
might be needed to achieve a detection rate of > 99% in 
BSIs.  Thus, the authors observed that the cumulative yield 
of pathogens from three blood culture sets (2 bottles per set) 
with a 20 mL blood volume in each set (10 mL per bottle) 
was 73.1% for the first set, 89.7% – the first two sets and 
98.3% – the first three sets [46].
Most studies emphasize that, it is not generally recom-
mended for adult patients to collect a single bottle or a sin-
gle blood culture sample set since this practice will result in 
insufficient BC volume and failure to detect the causative 
agent in a considerable number of bacteremias [43].
Furthermore, international guidelines recommend col-
lecting 2, or preferably 3 blood culture sample sets for each 
septic episode in order to differentiate BC contamination 
during sampling of true bacteremia. In case of BC contami-
nation, the microbial flora will be present in only one bottle 
or a set of blood culture bottles, unlike true BSI, in which 
multiple bottles or sets will be positive. In case of 2-3 blood 
culture sets sampling, followed by a 24-48 hour incubation 
period, the results are negative and the patient is still septic, 
2-3 additional BCs should be taken [15, 22, 42].
A number of studies have described the variety and 
usefulness of inoculation of blood culture media. Various 
BSI-causing microorganisms (aerobic and anaerobic patho-
gens, fungi, fastidious microorganisms, etc.) require specific 
growth factors and incubation conditions. In cases when a 
patient is administered antimicrobial therapy, specialized 
media with antibiotic neutralization factors should be used. 
Some studies have shown that media, containing antibiotic 
inhibitors, increase the degree of isolation and identification 
of pathogens in a shorter time compared to standard media 
[47-50]. 
An essential element in blood culture sampling is the 
sequence of bottles inoculation. Therefore, when using vac-
uum blood-sampling system, the blood is first transferred 
into the aerobic bottle to prevent transfer of air from the 
sampling device to the anaerobic bottle. When using a nee-
dle or syringe, the anaerobic bottle is first inoculated to avoid 
air ingress. If the taken blood volume is less than the recom-
mended one, then 10 ml of blood is first inoculated into the 
aerobic bottle, as most bacterial cases are caused by aerobic 
and facultatively anaerobic bacteria. In addition, pathogenic 
fungi and strictly aerobic bacteria (e.g. Pseudomonas spp.) 
are almost exclusively isolated from aerobic bottles. Any re-
maining blood amount is recommended to be inoculated 
into the anaerobic bottle [11].
The study analysis reported that the time interval be-
tween taking two blood samples is not considered a critical 
factor, since the yield of diagnosis remains the same [51].
At the same time, international guidelines recommend 
that the first two / three blood culture sets (two bottles / 
set) should be obtained over a short period of time (e.g. 
within one hour) or as a single sample taken at one time. 
Blood sampling at long intervals, such as 1-2 hour intervals, 
is recommended when monitoring continuous bacteremia/
fungemia in patients with suspected infective endocarditis 
or other endovascular infections [32, 43].
In severe infections or to increase detection sensitivity 
(e.g. pyelonephritis), two or three additional blood culture 
sets are collected, in case if the first 2-3 hemocultures are 
negative after 24-48 hours of incubation. Moreover, the 
time interval depends on the suspected BSI-causing agents: 
the sensitivity is relatively good for such microorganisms 
as Escherichia coli or Staphylococcus aureus, and lower for 
Pseudomonas aeruginosa, streptococci or fungi [52].
Methods and techniques for the processing and 
interpretation of blood culture results
Most microbiology laboratories use incubation, auto-
mated continuous monitoring, shaking, and automated 
blood culture systems. Many manufacturers provide such 
devices with almost similar performance characteristics 
[53-56].
Automated systems place the BC bottles for a predeter-
mined incubation period, giving a visual or warning signal 
if increase is detected. Each automated blood culture system 
produces its own media, which should be carefully assessed 
and selected by the user. The blood culture bottles typically 
contain culture medium approved mixtures, anticoagulants 
and, in many cases, resins or coal mixtures to neutralize 
antimicrobial and other toxic compounds. Commonly, the 
mixture of different substances is complementary to each 
other and is chosen to improve the range of bacterial life, in-
cluding the fastidious microorganisms. Blood culture media 
formulas allow the detection of aerobes (including fungi), 
anaerobes and mycobacteria [51, 57, 22].
Other studies, comparing the performance of media 
with and without the addition of antimicrobial neutralizing 
agents (resins and / or coal compounds), have repeatedly 
demonstrated that these substances are obviously superior 
in the recovery of microorganisms, particularly the fastidi-
ous ones and levuriform mycetes [58-60].
Studies in the field examined the requirements for blood 
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culture media and highlight the most essential rule to be 
followed. Thus, media must be sufficiently sensitive to yield 
a wide range of clinically relevant microorganisms, even the 
most fastidious ones (e.g. .Neisseria spp., Haemophilus spp.) 
or that require lower amount of CO2 (e.g., Brucella spp., 
Acinetobacter spp.) [57, 61].
Blood cultures are usually incubated for 5 days via au-
tomated systems. Multiple studies have proven that this is 
an appropriate incubation period  for detection of most 
pathogens, including the bacterial strains like Haemophilus, 
Actinobacillus, Cardiobacterium, Eikinella and Kingella 
(HACEK) group, whereas the incubation period over 5 days 
increases the number of contaminant isolates [62, 63].
However, studies emphasize that a longer incubation pe-
riod is required in case of suspected fungemia or bacteremia 
caused by Legionella, Brucella, Bartonella or Nocardia spp. 
Mycobacterial and blood culture should be incubated for 4 
weeks [64, 65].
Bloodstream infections of suspected fungal etiology do 
not require special culture media since most fungi grow on 
conventional aerobic media within 2 to 3 days. Candida gla-
brata and Cryptococcus neoformans are exceptions to this 
rule that usually require 3 to 5 days of incubation. Fusarium 
and Paecilomyces can be isolated in the conventional blood 
culture broth, while other filamentous fungi are not detect-
ed [61, 66].
Furthermore, there are no sufficient data on dimorphic 
fungi growth, such as Histoplasma and Blastomyces, which 
grow in blood culture broth requiring more than 2-week in-
cubation period. Therefore, some studies recommend that 
slow growth of fungi and fastidious bacteria should be car-
ried out via more specialized systems such as the lysis cen-
trifugation system [67].
BSI-diseased patients, under certain circumstances, are 
often administered antimicrobials prior to sampling, thus 
suppressing the bacterial and fungal growth. Therefore, 
manufacturers of blood culture systems might complement 
their own media formulations with antibiotic binding resins 
or absorbent carbon. The analysis of these compounds char-
acteristics has shown significant outcomes in the absorption 
of antibacterial and antifungal preparations, thus increasing 
bacterial and fungal yield rates and reducing the detection 
time of positive cultures [58, 68-70].
The identification of BSI causative agents can be per-
formed by both manual technique and automated systems. 
This technique is initiated by taking a Gram stain, which is 
absolutely necessary for the management of these samples. 
A positive Gram stain with gram positive or negative micro-
bial flora identification is immediately reported to the clini-
cian in order to provide prompt antimicrobial therapy and 
measures of controlling these infections. Subcultures are 
performed later on, to allow identification and susceptibil-
ity testing to be carried out normally within the next 24–48 
hours. Laboratories should have a standardized protocol to 
guide the lab staff activity on blood sampling in order to 
optimize the use of resources for complete organism identi-
fication and organism-specific susceptibility testing of clini-
cally important organisms that are probably the contami-
nating flora [71, 72].
Interpretation of positive blood culture results is often 
simple, but sometimes presents a dilemma for both clini-
cians and microbiologists. Therefore, laboratory data must 
be evaluated in the context of clinical symptoms to achieve 
an accurate interpretation. A true positive blood culture re-
sult is obtained when most or all of the blood culture sets, 
withdrawn by independent venipuncture, are positive for 
the same microorganism. Thus, the probability that the 
isolated microorganism represents the BSI-causing agent is 
very high, regardless of the organism’s identity [52].
The identification of microorganisms isolated from posi-
tive blood cultures is also significant, namely: Staphylococcus 
aureus, Streptococcus pneumoniae, Enterobacteriaceae, 
Pseudomonas aeruginosa and Candida albicans are almost 
always predictive of true BSI. However, Corynebacterium 
spp. and Propionibacterium spp. often represent the contami-
nating flora. Isolation of viridans group streptococci, coagu-
lase-negative staphylococci (CoNS) and enterococci is more 
difficult to interpret, as some studies have reported that they 
cause BSIs in 38%, 15% and 78%, respectively. Coagulase-
negative staphylococci are particularly the most common 
blood culture contaminants. Moreover, a number of studies 
have reported that these microorganisms have an obvious 
clinical importance in BSI etiology among patients with im-
planted medical devices and localized catheters. Therefore, 
the accurate result interpretation can be achieved, when a 
few sets of blood cultures are positive with the same CoNS 
species. Under these circumstances, the probability of these 
microorganisms to represent the true cause of bacteremia is 
much higher [73].
Rapid methods for identification and susceptibility test-
ing of blood culture isolates responsible for BSI are crucial 
and may guide clinicians in decision-making on therapeutic 
interventions. Blood cultures incubated in modern systems 
commonly signal a positive result in a mean time of 12-36 
hours, whereas the positive time from sampling to detection 
is longer for some fastidious microorganisms, anaerobes 
and fungi [55, 56].
According to the microbilogical protocols on blood cul-
ture sampling, even from the initial steps, the gram stained 
smear provides immediate useful information to the cli-
nician, who might determine both the importance of the 
positive result and / or the initial antimicrobial therapy. 
Compliance with standard microbiological protocols, based 
on the biochemical identification of microorganisms and 
antimicrobial susceptibility testing, allow the adjustment 
of antimicrobial therapy after 48-72 hours. However, mi-
croorganisms that are difficult to be identified biochemi-
cally or slowly grow “in vitro”, may require a longer period. 
Therefore, the prolonged result delivery (3-5 days from the 
blood culture collection to final identification and testing of 
antimicrobial susceptibility) is one of the main challenges 
encountered within the microbiology laboratory. In this 
context, the researchers highlight the continuous interest to 
reduce this time by developing rapid methods. For example, 
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the coagulase test, traditionally used to distinguish CoNS 
isolates from coagulase-positive isolates, can be conducted 
directly on positive blood culture broths, containing Gram-
positive cocci on Gram staining [74].
This approach allows a rapid distinction between CoNS 
and coagulase-positive staphylococci (for example, S. au-
reus) and may influence clinicians’ ability to interpret the 
clinical significance of a positive blood culture result and 
initiate an appropriate antimicrobial therapy. Clearly, this is 
not a complete solution as it does not definitively detect the 
micro-organism and does not provide data on susceptibil-
ity. Similarly, it is possible to couple direct coagulase testing 
with the use of chromogenic media, which allows identifica-
tion of methicillin-resistant S. aureus isolates within 18-24 
hours [75].
Some studies come with stronger evidence and approach 
to improve the laboratory diagnosis of BSIs by using new 
and rapid methods. Molecular methods, including nucleic 
acid amplification assays (NAATs) and DNA sequencing ap-
proaches have emerged as highly useful tools for identifying 
microorganisms and, in some cases, predicting antimicro-
bial susceptibility for selected antibiotics [76-79] .
Furthermore, a series of studies have proven that novel 
phenotypic approaches reduce the time for identification 
and antimicrobial susceptibility testing for selected micro-
organisms [80].
Researchers also describe another rapid method, such as 
Mass Spectrometry, which is widely used within clinical mi-
crobiology laboratories as a routine method for rapid iden-
tification of microorganisms directly from positive blood 
culture broth [81, 82].
This method provides much more specific results within 
a limited time, regarding the microorganism identification 
and the present resistance mechanisms, compared to tradi-
tional methodology. Clinicians should get familiar with the 
criteria for interpreting these results, as well as the initial an-
timicrobial treatment schemes and subsequent adjustment 
of therapy on the basis of final outcomes [83, 67].
Therefore, these methods can only be used as additional 
assessment to the already existing standard protocols on 
BSI patient management. Many infections show similar 
clinical picture, whereas the laboratory diagnosis of infec-
tious diseases is limited to testing, as only the most com-
mon pathogens are associated with clinical syndrome. Thus, 
it results in a number of undiagnosed infections, requiring 
additional sampling, patient dissatisfaction and a compro-
mised health care. The syndrome-related approach to diag-
nosing infectious diseases might change this situation. This 
might become a symptom-based diagnostic method that 
might assess multiple common pathogens using a single 
rapid test (multiplex PCR). This method allows physicians 
to quickly choose the right test and improve treatment man-
agement for a number of infections. Hospital-related mor-
tality rate among septic patients ranges from 10% to 50%. 
Inappropriate antimicrobial therapy for septic shock occurs 
in approximately 20% of patients and is associated with a 
fivefold reduction in patient survival rate. Rapid diagnosis 
and targeted treatment might prevent up to 80% of sepsis-
related deaths [84, 85].
Rapid multiplex PCR systems used in positive blood 
culture sampling detect over 20 types of microorganisms, 
including antibiotic-resistant genes (carbapenemases, 
MRSA, VRE), which provide fast and reliable results within 
several hours for rapid clinical decision-making. Ease of 
sample collection, rapidity and ability to cover a wide range 
of pathogens, including the antibiotic- resistant genes, pro-
vide excellent laboratory opportunities for delivering data 
for further positive care assistance among patients with BSIs 
[86, 87].
Unlike the traditional blood culture method, the multi-
plex PCR system rapidly reduces the time required for iden-
tification of microorganisms in positive BC bottles, viz. from 
26.5 hours to less than 3 hours. The mean time required to 
identify the potential antibiotic resistance mechanisms was 
2.2 hours, whereas the results of bacterial antibiotic sensitiv-
ity testing (phenotypic) were available within 33.3 hours on 
average. The multiplex PCR system test accurately identified 
the presence or absence of antibiotic resistance mechanisms 
in all 70 bacteria detected within the study (35 samples with 
S. aureus, 6 – Enterococcus spp., 29 – Enterobacteriaceae and 
P. aeruginosa). These study results allowed clinicians to ad-
just an empirical combined treatment in 22 out of 112 pa-
tients [88].
Most studies emphasize the importance of implementa-
tion of rapid diagnostic solutions along with manual meth-
od of BC sampling, in order to identify and differentiate the 
underlying pathogens of BSI etiology. The implementation 
of these rapid diagnostic methods (multiplex PCR) is cru-
cial in urgent therapeutic management and patient follow-
up, which helps reduce the intervention time and targeted 
treatment, as well as additional sampling and length of hos-
pitalization [88].
Overall considerations on blood  
culture contamination
Inappropriate practices result in blood culture con-
tamination with skin commensals on the venipuncture site. 
Blood culture contamination during the sampling process 
may lead to false positive results, which may have a nega-
tive impact on the patient condition. A false positive re-
sult  is defined as an increase of bacteria in the blood cul-
ture bottle that are not normally present in patient’s blood , 
which might have been introduced during blood sampling. 
Contamination may originate from a number of sources: 
the patient’s skin, the equipment used for sampling, the 
hands of the person taking the blood sample or the environ-
ment [61, 81].
Taking uncontaminated blood specimens is essential 
in providing a blood culture result that has a clinical value. 
Certain microorganisms such as coagulase-negative staphy-
lococci and streptococci from the group of Viridans, Bacillus 
spp, Propionibacterium spp., Difteroides, Micrococcus spp 
may rarely cause severe bacterial infections or BSIs. These 
microorganisms are common skin contaminants and, al-
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though they are able to cause severe infections, under appro-
priate conditions, their detection in a single, blood culture 
set can be reasonably identified as a possible contaminant 
with no clinical significance. However, coagulase-negative 
staphylococci are considered the primary cause of catheter-
associated infections and may exhibit clinical significance in 
up to 20% of cases [19].
The most difficult challenge for physicians is to interpret 
whether the microorganism isolated from a blood culture 
is a BSI-causing pathogen or a contaminant. If it is a con-
taminant, the antibiotic therapy in patients is unnecessary 
or inappropriate, resulting in life-threatening condition and 
additional costs for the health care assistance. The microbial 
isolate should be distinguished as a real etiological factor 
from the contaminant one, based on venipuncture blood 
sampling or via an intra-vascular device and multiple isola-
tion of the same species of microorganisms. Therefore, it is 
highly important to include information regarding the site 
of blood culture sampling in the application form before 
sending the sample to the laboratory [32].
Prevention of blood culture contamination
 The most effective way to reduce contamination rate is 
to strictly comply with the rules of hand hygiene, as well as 
follow the best practices in blood sampling, skin processing, 
venipuncture and blood transfer in BC bottles. However, al-
though the best blood sampling protocols have been carried 
out, it is impossible to reduce the contamination rate below 
2% [37, 61, 89].
The American Society for Microbiology (ASM) and 
CLSI recommend that the contamination rates should not 
exceed 3% of the total of collected sets [32].
The study outcomes on the analysis of contamination 
sources showed a good understanding of blood culture 
sampling time but described a variety of methods and 
equipment used. Subsequently, the study authors suggested 
measures on rationalization and standardization of blood 
sampling equipment and techniques, as well as personnel 
training regarding their compliance. This project operated 
for 12 months within an Emergency Department and suc-
cessfully reduced local contamination rates up to 2.0% [90].
Blood culture contamination of skin microbiota is an 
important issue regarding the patient outcome and manage-
ment, and might lead to inappropriate use of antibiotics, ad-
ditional laboratory and radiological tests, antimicrobial side 
effects and increased length of hospitalization [91].
Personnel training in sampling, processing and 
interpretation of blood cultures
Education and professional training of medical staff 
(doctors, nurses, phlebotomists or technicians), engaged in 
caring of patients with BSIs is paramount in developing best 
clinical practices and preventing blood culture contamina-
tion [22, 92-94].
Over the last decades, a number of studies have focused 
on the study of causes and measures to prevent blood culture 
contamination. Thus, according to some authors, training of 
the staff on the proper sampling techniques, monitoring of 
blood culture contamination rates and getting familiar with 
these data might reduce the contamination rate [95, 22].
Other studies have reported that continuous training 
and their efficiency assessment have been associated with 
lower rates of blood culture contamination (from 2.59% to 
2.23%). Moreover, the decrease in the contamination rates 
from 5.7% to 1.95% due to personnel training was registered 
in other studies, as well [96].
Studies that described the use of combined interactive 
learning methods (video materials, simulations for develop-
ing practical skills), and determined their impact on blood 
culture contamination rates were performed. The study re-
vealed that contamination rates remained the same, except 
for the experienced staff (from 4.1% to 2.7%), hence theo-
retical education is considered inefficient without coherent 
practices [95, 96].
A group of researchers demonstrated a decrease of 44% 
in the contamination rate (from 1.82% to 1.01%) as a result 
of personal training and counseling. Considerable results 
(from 11.8% to 7.4%) were recorded when using the same 
mechanisms (individual training and counseling) but with 
more frequent sessions, e.g. twice a month [22, 96].
Another approach in staff training on good practices, 
in terms of preventing blood culture contamination, was 
conducted by another group of researchers, who introduced 
theoretical education along with proper using of blood cul-
ture sampling containers, hence reporting a decrease of 42% 
in the contamination rate [95].
Thus, the reviewed studies presented evidence-based 
data on the importance of staff training in sampling, pro-
cessing and interpretation of blood cultures, using various 
interactive methods, as well as counseling sessions in terms 
blood culture sampling.
In order to increase the yield of BSI-causing pathogens, 
as well as to obtain fast and reliable outcomes, prevent blood 
culture contamination and improve patient management of 
BSIs, it is paramount to implement a standardized algo-
rithm for the sampling, processing and interpretation of 
blood cultures.
Conclusions
1. Bloodstream infections represent a serious medical is-
sue for public health care worldwide, as well as a challenge 
in their diagnosis and management.
2. Data collection on BSI etiology and microorganism 
resistance at a regional level provides a rational basis for 
optimizing further potential preventive strategies such as 
immunization, environmental hygiene and chronic disease 
management.
3. Implementation and compliance to a standardized al-
gorithm, blood culture identification by the clinician, and 
proper sampling procedure will help increase the pathogen 
isolation rate of BSIs.
4. The epidemiological surveillance of these infections 
is a continuous and permanent multidisciplinary activity of 
healthcare professionals.
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5. Standardization of blood culture sampling methods, 
blood volume optimization, using of a checklist, using effec-
tive antiseptics and staff training, lead to the development of 
good practices for collecting blood culture samples and thus 
reducing their contamination at the lowest possible rate, not 
more than 2%.
6. Education of medical staff, trained in the sampling, 
processing and interpretation of blood cultures is vital for 
improving patient care and management in case of BSIs.
7. The study calls attention to insufficient data on patient 
evolution with BSI due to misdiagnosis, resulting in irra-
tional microbial administration and uncontrolled spread of 
MDR microorganisms that generally occur within the hos-
pital and community.
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